Medical-grade exoskeleton devices used for rehabilitation training or mobility assistance are classified as medical devices in most markets and require approval by drug regulatory authorities; in China they are Class II or Class III medical devices under NMPA, in the United States they follow the FDA's 510(k) or De Novo pathway, and the clinical validation cycle typically takes years.